info@news-matic.com

Privacy Terms Contact
AirHelp travel assistance ad
ads-image
ads-image

OPKO Health’s ModeX Therapeutics Begins Clinical Trial of Tetraspecific Antibody for Treatment of B-cell Lymphomas

Patients dosed in Phase 1 safety and tolerability study of MDX2003, a novel T-cell engager designed to optimize killing of lymphomas

In This Category

details
Berkeley school district delays Longfellow Middle
details
Trump Extends Iran Ceasefire While Maintaining Nav
details
Bear Grylls Says Matthew McConaughey “Always Had A
details
Planters Broadband Selects Ribbon to Launch New 40
details
ads-image
ads-image
Ad 1
Ad 2
Ad 3

Get in Touch

info@news-matic.com

Latest Post

Quick Links

Newsletter

Terms of use Privacy policy Cookies Accessibility help Advertise with us Contact us Sitemap
Ad 1
Ad 2
Ad 3

2026 Copyright © News-Matic.com. All Rights Reserved

Cookie Consent + Tracking